Q R J G Tummers1, F P R Verbeek1, B E Schaafsma1, M C Boonstra1, J R van der Vorst1, G-J Liefers1, C J H van de Velde1, J V Frangioni2, A L Vahrmeijer3. 1. Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. 2. Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA; Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA. 3. Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: a.l.vahrmeijer@lumc.nl.
Abstract
BACKGROUND: Despite recent developments in preoperative breast cancer imaging, intraoperative localization of tumor tissue can be challenging, resulting in tumor-positive resection margins during breast conserving surgery. Based on certain physicochemical similarities between Technetium((99m)Tc)-sestamibi (MIBI), an SPECT radiodiagnostic with a sensitivity of 83-90% to detect breast cancer preoperatively, and the near-infrared (NIR) fluorophore Methylene Blue (MB), we hypothesized that MB might detect breast cancer intraoperatively using NIR fluorescence imaging. METHODS: Twenty-four patients with breast cancer, planned for surgical resection, were included. Patients were divided in 2 administration groups, which differed with respect to the timing of MB administration. N = 12 patients per group were administered 1.0 mg/kg MB intravenously either immediately or 3 h before surgery. The mini-FLARE imaging system was used to identify the NIR fluorescent signal during surgery and on post-resected specimens transferred to the pathology department. Results were confirmed by NIR fluorescence microscopy. RESULTS: 20/24 (83%) of breast tumors (carcinoma in N = 21 and ductal carcinoma in situ in N = 3) were identified in the resected specimen using NIR fluorescence imaging. Patients with non-detectable tumors were significantly older. No significant relation to receptor status or tumor grade was seen. Overall tumor-to-background ratio (TBR) was 2.4 ± 0.8. There was no significant difference between TBR and background signal between administration groups. In 2/4 patients with positive resection margins, breast cancer tissue identified in the wound bed during surgery would have changed surgical management. Histology confirmed the concordance of fluorescence signal and tumor tissue. CONCLUSIONS: This feasibility study demonstrated an overall breast cancer identification rate using MB of 83%, with real-time intraoperative guidance having the potential to alter patient management.
BACKGROUND: Despite recent developments in preoperative breast cancer imaging, intraoperative localization of tumor tissue can be challenging, resulting in tumor-positive resection margins during breast conserving surgery. Based on certain physicochemical similarities between Technetium((99m)Tc)-sestamibi (MIBI), an SPECT radiodiagnostic with a sensitivity of 83-90% to detect breast cancer preoperatively, and the near-infrared (NIR) fluorophore Methylene Blue (MB), we hypothesized that MB might detect breast cancer intraoperatively using NIR fluorescence imaging. METHODS: Twenty-four patients with breast cancer, planned for surgical resection, were included. Patients were divided in 2 administration groups, which differed with respect to the timing of MB administration. N = 12 patients per group were administered 1.0 mg/kg MB intravenously either immediately or 3 h before surgery. The mini-FLARE imaging system was used to identify the NIR fluorescent signal during surgery and on post-resected specimens transferred to the pathology department. Results were confirmed by NIR fluorescence microscopy. RESULTS: 20/24 (83%) of breast tumors (carcinoma in N = 21 and ductal carcinoma in situ in N = 3) were identified in the resected specimen using NIR fluorescence imaging. Patients with non-detectable tumors were significantly older. No significant relation to receptor status or tumor grade was seen. Overall tumor-to-background ratio (TBR) was 2.4 ± 0.8. There was no significant difference between TBR and background signal between administration groups. In 2/4 patients with positive resection margins, breast cancer tissue identified in the wound bed during surgery would have changed surgical management. Histology confirmed the concordance of fluorescence signal and tumor tissue. CONCLUSIONS: This feasibility study demonstrated an overall breast cancer identification rate using MB of 83%, with real-time intraoperative guidance having the potential to alter patient management.
Authors: Alexander L Vahrmeijer; Merlijn Hutteman; Joost R van der Vorst; Cornelis J H van de Velde; John V Frangioni Journal: Nat Rev Clin Oncol Date: 2013-07-23 Impact factor: 66.675
Authors: M Clarke; R Collins; S Darby; C Davies; P Elphinstone; V Evans; J Godwin; R Gray; C Hicks; S James; E MacKinnon; P McGale; T McHugh; R Peto; C Taylor; Y Wang Journal: Lancet Date: 2005-12-17 Impact factor: 79.321
Authors: Joost R van der Vorst; Alexander L Vahrmeijer; Merlijn Hutteman; Tjalling Bosse; Vincent T H B M Smit; Cornelis J H van de Velde; John V Frangioni; Bert A Bonsing Journal: World J Gastrointest Surg Date: 2012-07-27
Authors: Stefan Harmsen; Nutte Teraphongphom; Michael F Tweedle; James P Basilion; Eben L Rosenthal Journal: Mol Imaging Biol Date: 2017-06 Impact factor: 3.488
Authors: Shadi A Esfahani; Pedram Heidari; Melanie H Kucherlapati; Jorge M Ferrer; Raju S Kucherlapati; Umar Mahmood Journal: Am J Nucl Med Mol Imaging Date: 2019-10-15
Authors: Stephen A Boppart; J Quincy Brown; Camile S Farah; Esther Kho; Laura Marcu; Christobel M Saunders; Henricus J C M Sterenborg Journal: J Biomed Opt Date: 2017-12 Impact factor: 3.170
Authors: Melodi Javid Whitley; Diana M Cardona; Alexander L Lazarides; Ivan Spasojevic; Jorge M Ferrer; Joan Cahill; Chang-Lung Lee; Matija Snuderl; Dan G Blazer; E Shelley Hwang; Rachel A Greenup; Paul J Mosca; Jeffrey K Mito; Kyle C Cuneo; Nicole A Larrier; Erin K O'Reilly; Richard F Riedel; William C Eward; David B Strasfeld; Dai Fukumura; Rakesh K Jain; W David Lee; Linda G Griffith; Moungi G Bawendi; David G Kirsch; Brian E Brigman Journal: Sci Transl Med Date: 2016-01-06 Impact factor: 17.956